Table 3.
Distribution of individual Type 2 inflammatory biomarkers
| Threshold | Always below threshold | Crossing the threshold | Persistently above threshold | |
|---|---|---|---|---|
| Blood eos | 150 cells/μL, n (%) | 20 (8.5) | 139 (57.6) | 82 (33.9) |
| 300 cells/μL, n (%) | 39 (16.1) | 149 (61.9) | 53 (22.0) | |
| 400 cells/μL, n (%) | 75 (31.3) | 141 (58.5) | 25 (10.2) | |
| 500 cells/μL, n (%) | 92 (38.1) | 137 (56.8) | 12 (5.1) | |
| FeNO | 19.5 ppb, n (%) | 26 (10.9) | 69 (28.6) | 146 (60.5) |
| 25 ppb, n (%) | 34 (14.3) | 85 (35.3) | 121 (50.4) | |
| 50 ppb, n (%) | 83 (34.5) | 117 (48.7) | 40 (16.8) | |
| Blood eos + FeNO | 19.5 ppb + 260 cells/μL, n (%) | 47 (19.5) | 166 (68.8) | 28 (11.7) |
| 25 ppb + 300 cells/μL, n (%) | 56 (23.4) | 162 (67.2) | 23 (9.4) | |
| Sputum eos | 3%, n (%) | 9 (5.2) | 82 (47.4) | 82 (47.4) |
| Serum total IgE | 30 IU/mL, n (%) | 0 (0) | 1 (1.9) | 61 (98.1) |
eos, eosinophils. FeNO, fraction of exhaled nitric oxide. IgE, total immunoglobulin E